ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.2644
Delayed Data
As of Jun 22
 -0.0024 / -0.92%
Today’s Change
0.17
Today|||52-Week Range
2.79
-16.33%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for ImmunoCellular Therapeutics Ltd have a median target of 42.50, with a high estimate of 80.00 and a low estimate of 5.00. The median estimate represents a +15,974.13% increase from the last price of 0.26.

Analyst Recommendations

There are no recommendations available.

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually 47.97%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.